Ingredient selection & rationale
Evidence-based active selection with dose justification for every slot in the formula.
Service · Formulation Development
Your product idea deserves more than a generic formula off a manufacturer's shelf. We develop custom formulations built from the ground up, grounded in biochemistry, aligned with Australian regulatory standards, and designed to actually work.
Scope
Evidence-based active selection with dose justification for every slot in the formula.
Capsules, tablets, powders, gummies, liquids and topicals, with the base engineered for the format.
Interaction screening before the pilot batch, not after the first customer complaint.
Built to TGA Listed Medicine and ARTG requirements from the first draft.
Ingredient screening for halal and plant-based product lines.
A client-owned document you can hand to any manufacturer.
Protocol
Thirty minutes to scope the brief, the market and the regulatory pathway.
Literature review, dosage modelling and draft matrix, delivered as a dossier.
The dossier goes to your manufacturer with a structured technical brief.
Sampling and iteration until the batch matches the brief.
For founders, brand managers and entrepreneurs developing a custom product, particularly halal or plant-based lines.
Questions
No. Most briefs arrive as an idea and a market rather than a specification, and no scientific background is assumed; every decision is explained in plain terms. Bring the concept, the competitors and the claims you want to make, and the discovery call turns them into a scope.
No, and that is deliberate. We sit upstream of manufacturing and take nothing from it, so an active is chosen because the evidence supports it, not because a particular plant already stocks it.
You do. Full IP is assigned to you at handover, and that includes the reasoning behind every ingredient and dose rather than the final matrix alone. The formula is yours to take to any manufacturer.
Yes. Reformulation and optimisation run through the same formulation step, whether the goal is a cleaner label, a better-absorbed form of an active, or a product that has stopped performing against its competitors.
We design and specify the testing; an independent laboratory runs it. It is an optional add-on, quoted separately, so a brief that does not need it is not paying for it.
Indicatively around sixteen weeks end to end, though that moves with category, complexity and testing. Scope and price are fixed per phase and confirmed after the discovery call, with milestone payments rather than a lump sum.
Next step
A focused conversation to understand your product and scope what's possible. No pressure, no pitch.